A company is working on a new COVID-19 test that can scale to 1 million tests per day by re-purposing existing infrastructure, eliminating RNA extraction, and enabling a distributed system. The test uses a reference sequencing signal to distinguish between viral RNA and other signals. The company plans to make the test available for COVID-19 testing without seeking financial gain, as long as the end-user is not selling the test kits. The test's development and implementation are discussed in the comments, including its potential impact and limitations.